Literature DB >> 26190721

Asymptomatic curable pancreatic ductal carcinoma detected during the follow-up of pancreatic cysts distinct from carcinoma.

Natsuko Kawada1, Hiroyuki Uehara2, Kazuhiro Katayama1, Sachiko Tanaka3, Rena Takakura3, Yasuna Takano3, Tatsuya Ioka3, Miho Nakao3, Kazuho Imanaka1, Kazuyoshi Ohkawa1, Akemi Takenaka4, Yasuhiko Tomita5, Osamu Ishikawa6.   

Abstract

Recent studies have reported that pancreatic ductal carcinomas are frequently found during the follow-up of pancreatic cysts distinct from carcinoma; however, the majority of them are detected in advanced stages. Therefore, the early detection of metachronous ductal carcinomas is one of the issues in the management of pancreatic cysts. A 25-mm pancreatic cyst in the pancreatic head was found during an annual check-up in a 70-year-old woman. She was followed up every 6 months by abdominal ultrasound (US) and blood tests, and every 12 months by an additional magnetic resonance imaging scan. Twelve months later, abdominal US revealed a suspicious low-echoic area of 17 mm diameter in the pancreatic body. Eighteen months later, her serum carbohydrate antigen 19-9 level rose to 92 U/ml. Endoscopic retrograde pancreatography demonstrated a strictured main pancreatic duct (MPD) of 15 mm in length in the pancreatic body. A cytological examination of the brushed MPD revealed adenocarcinoma. The patient underwent distal pancreatectomy and splenectomy after chemoradiotherapy. An histological examination revealed a ductal carcinoma of 26 mm diameter in the pancreatic body, which was successfully resected. This case might help to establish an optimal surveillance method to detect metachronous ductal carcinomas arising from the pancreas harboring cystic lesions.

Entities:  

Keywords:  Ductal carcinoma; Intraductal papillary mucinous neoplasm; Pancreas; Pancreatic cyst

Year:  2011        PMID: 26190721     DOI: 10.1007/s12328-011-0210-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  19 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

Authors:  Hiroaki Ohigashi; Osamu Ishikawa; Hidetoshi Eguchi; Hidenori Takahashi; Kunihito Gotoh; Terumasa Yamada; Masahiko Yano; Akihiko Nakaizumi; Hiroyuki Uehara; Yoshihiko Tomita; Kinji Nishiyama
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

3.  Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Authors:  Carlos Fernández-del Castillo; Javier Targarona; Sarah P Thayer; David W Rattner; William R Brugge; Andrew L Warshaw
Journal:  Arch Surg       Date:  2003-04

4.  A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.

Authors:  Peter J Allen; Michael D'Angelica; Mithat Gonen; David P Jaques; Daniel G Coit; William R Jarnagin; Ronald DeMatteo; Yuman Fong; Leslie H Blumgart; Murray F Brennan
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Terumi Kamisawa; Yuyang Tu; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

7.  High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions.

Authors:  K Tateishi; M Tada; M Yamagata; H Isayama; Y Komatsu; T Kawabe; Y Shiratori; M Omata
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

8.  Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thun Ingkakul; Yoshihiko Sadakari; Jun Ienaga; Norihiro Satoh; Shunichi Takahata; Masao Tanaka
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

9.  Quantity of mutant K-ras gene in pancreatic secretions for diagnosis of pancreatic carcinoma with different assays: analysis of 100 patients.

Authors:  Minoru Tada; Keisuke Tateishi; Takao Kawabe; Naoki Sasahira; Hiroyuki Isayama; Yutaka Komatsu; Yasushi Shiratori; Masao Omata
Journal:  Clin Chim Acta       Date:  2002-10       Impact factor: 3.786

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  1 in total

1.  Pancreatic cancer accompanied by a moderate-sized pseudocyst with extrapancreatic growth.

Authors:  Yu Ohkura; Kazunari Sasaki; Masamichi Matsuda; Masaji Hashimoto; Takeshi Fujii; Goro Watanabe
Journal:  BMC Med Imaging       Date:  2015-05-07       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.